An overview on the Balloon Catheter Market (2023 to 2033)

The global balloon catheter demand is subjected to growth at a CAGR of 4.3%. The market revenue is likely to be valued at USD 4.2 Billion in 2023 and exhibit a revenue growth of USD 6.4 Billion by 2033.

Key players aim at providing balloon catheter technologies that offer the excellent performance required to succeed in difficult circumstances. Furthermore, their exclusive laser-bonded method produces an exceptional TrakTipTM design as well as accurate, smooth bonding along the shaft. These also provide occlusion balloon catheters, which are particularly intended to minimize stone fragment movement down the ureter during PCNL treatments.

Mustang, created by a specific market player, improves patient outcomes because of its reduced sheath diameters. Mustang is meant to facilitate and speed up the operation by having superior cross and track, forceful dilatation, and longer lengths.

To ease strictures and allow the implantation of bigger surgical tools, consumers may always employ a balloon dilatation catheter developed for radial dilatation of the urinary tract. Furthermore, when reaching distant lesions in tiny veins below the knee, end users prefer PTA quick exchange balloon dilatation catheter.

Clinicians may also use the chameleon balloon catheter, which combines the functions of a high-pressure balloon catheter with a diagnostic catheter - allowing for the proximal administration of diagnostic fluids (such as contrast media) and therapeutic fluids. Key companies provide a comprehensive coronary portfolio that includes effective lesion preparation and treatment options. Their next-generation stents and balloon catheters enable polymer-free medication delivery for better clinical outcomes.

Over the previous 12 years, the product family presented by the majority of market participants has proven its functionality and efficacy for coronary lesion treatment, as evidenced by a substantial clinical evidence portfolio comprising more than 110 published studies. A market player recently introduced a next-generation balloon dilatation catheter with high-pressure capacity. It is intended to improve the treatment of patients with coronary artery disease (CAD) during angioplasty treatments.

The product is presently accessible in the United States, Europe, and a few Asian and Latin American countries. The novel method is suitable for both pre-and post-dilatation treatments. VOYAGER NC can be used by physicians to negotiate convoluted anatomy and open up lesions before delivering a stent, or to expand a stent more precisely against the arterial wall once it has been implanted.

Balloon catheters introduced by the key players are designed for stent post- and pre-dilatation of refractory lesions. They also have limited compliance and longitudinal balloon expansion. It is solely employed to dilate the stenotic segment of a coronary artery with a balloon. Moreover, it may be used to bypass graft stenosis to improve myocardial perfusion and for post-dilatation of coronary stents.

Some key players have been successful in domestically producing an IABP (Intra-Aortic Balloon Pumping) balloon catheter, a first-aid device for myocardial infarction. They continue to outperform their competitors in the high-tech medical industry.

Attributes Details
Balloon Catheter Market HCAGR (2017 to 2022) 3.6%
Balloon Catheter Market CAGR (2023 to 2033) 4.3%
Market Size for Balloon Catheter (2023) USD 4.2 Billion
Market Size for Balloon Catheter (2033) USD 6.4 Billion

According to the World Health Organization (WHO) (2021), cardiovascular disease (CVD) is the leading cause of mortality globally, accounting for an estimated 17.9 Million deaths per year. Similarly, rising demand for minimally invasive operations, as well as an increase in the number of catheterization labs across the area, are likely to drive profitable growth during the projection period.

The majority of cardiovascular problems are treated with treatments such as percutaneous transluminal coronary angioplasty (PTCA), which makes heavy use of PTCA balloon catheters. As a result of the rising frequency of cardiovascular illnesses, a greater number of PCI operations are predicted to be performed. This is expected to create new balloon catheter market trends.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

A Contrast with the Historical Market Scenario:

According to the data compiled by Future Market Insights, the global forum of balloon catheters has experienced an exceptional growth in recent years. The market's leading providers are working in tandem with the growing demand for balloon catheters. The CAGR rate from 2017 to 2022 was 3.6%, and it is expected to increase to 4.3% during the forecast period.

Category-wise Insights:

Nylon - By Raw Material

By raw material type, the market is segmented into polyurethane, nylon, and others. The nylon sector is likely to have a large market share of 4.2% throughout the forecast period, according to Future Market Insights researchers.

The essential elements determining the velocity of this segment are:

  • Since nylon high-pressure balloons require a thicker wall for a given burst pressure, they have a broader profile than identical PET balloons when inserted into the body and bridging a lesion.
  • Owing to their qualities when inflated by volume, they may stretch 100% to 800% and are frequently utilized in applications that need the balloon to totally conform to or occlude the anatomy.

Coronary Artery Disease - By Indication Type

Based on indication, the market is segmented into coronary artery disease and peripheral vascular disease. According to Future Market Insights analysts, the coronary artery disease sector is expected to have a larger market share throughout the forecast period and may require the most balloon catheters.

The critical aspects driving the progression of this segment are:

  • According to World Health Organization (WHO) figures from 2017, coronary artery disease (CAD) is the most common kind of heart disease.
  • The World Health Organization (WHO) has also claimed that cardiovascular problems account for the bulk of non-communicable disease mortality.

How does the Product Recall Restrain Market Growth?

In the United States, balloon catheters are controlled by the Food and Drug Administration (FDA). The Food and Drug Administration and the United States agency in charge of medical device regulation give guidance on requirements for specific Class II applications. Consequently, the FDA's product recall is projected to hamper the market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Region-Wise Overview:

Country The United States
CAGR (2023 to 2033) 4.2%
HCAGR (2017 to 2022) 3.5%
Country The United Kingdom
CAGR (2023 to 2033) 4.8%
HCAGR (2017 to 2022) 5.5%
Country Germany
CAGR (2023 to 2033) 4.7%
HCAGR (2017 to 2022) 5.3%
Country China
CAGR (2023 to 2033) 4.8%
HCAGR (2017 to 2022) 4.2%
Country India
CAGR (2023 to 2033) 5.6%
HCAGR (2017 to 2022) 5.3%

Low-profile Cross-ability with Proven Clinical Effectiveness - The USA Market Players Transcending!

Attributes Details
USA Market Size (2033) USD 1.6 Billion
USA Market Absolute Dollar Growth (USD Million/Billion) USD 534.8 Million

North America is a significant balloon catheter market, particularly in the USA, which holds a revenue share of 4.2%. The value of the balloon catheter market in the USA is estimated to reach a high of USD 1.6 Billion. This is attributed to the availability of modern healthcare facilities and infrastructure, healthcare spending, and increased patient awareness.

In the United States, consumers choose balloon catheters with low-profile cross-ability and proven clinical effectiveness in crossing stent struts and bifurcations. Furthermore, significant companies provide balloon catheters with innovative shaft and tip technology, as well as an extended-size matrix that improves the balance of trackability and pushability.

The key market driver is the number of percutaneous coronary intervention (PCI) operations since a slight drop in the average selling price of devices is projected.

Purity, Symmetry, and Robustness: The Mantra of Balloon Catheter Providers in the United Kingdom!

Attributes Details
The United Kingdom Market Size (2033) USD 273.4 Million
The United Kingdom Market Absolute Dollar Growth (USD Million/Billion) USD 102.7 Million

Diabetes prevalence, government efforts, and the release of various technologically improved products by key manufacturers are anticipated to propel the balloon catheter market share in Europe, especially in the United Kingdom and Germany. The United Kingdom produces notable market potential, with a high-paced revenue growth rate of 4.8% and an anticipated value of USD 273.4 Million, throughout the projection period.

The United Kingdom has a considerable global market share among world-leading providers of high-quality balloon catheters. Their balloon catheters are exceptional in terms of purity, symmetry, and robustness, which are critical for certain medical device applications. Key players in the United Kingdom provide a variety of balloon catheters particularly developed to stop severe posterior nasal bleeding (epistaxis) that cannot be stopped by conventional means.

They aspire to advance the area of stroke care via continual, deliberate innovation that yields real results. This is accomplished by focusing on the advancement of less invasive stroke therapeutics.

Germany - Home to the Modern Drug-eluting Balloon Technology!

Attributes Details
Germany Market Size (2033) USD 244.3 Million
Germany Market Absolute Dollar Growth (USD Million/Billion) USD 89.8 Million

Germany is a lucrative balloon catheter market, growing at a profit of 4.7%. The value of the balloon catheter market in Germany is expected to reach a high of USD 244.3 Million. Germany is home to the most recent generation of drug-eluting balloon technology, which is meant to provide the same level of safety and performance as the best-in-class DES technology.

The core products offered by the key clinicians include stents (balloon-expandable and self-expandable), balloons for coronary and peripheral applications, catheters, and a wide variety of interventional cardiology and radiology accessories. Moreover, they provide components for the medical industry, such as specific tubes and sticky adhesives. They also provide a product search service, which includes the procurement of specialty items.

Key companies provide equipment designed exclusively for use as a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter to dilate de novo or restenosis coronary lesions for improving myocardial perfusion and reducing the incidence of restenosis. Furthermore, they provide the most comprehensive selection of PTCA drug-eluting balloon catheters, with balloon diameters ranging from 1.50 mm to 5.00 mm and lengths ranging from 10 mm to 40 mm.

Most key companies establish customer value through their lean organizational structure as medium-sized businesses. As a consequence, response times are reduced, unique client demands are met, and costs are reduced. Hence, they provide German-quality items at extremely reasonable pricing. Their goal is to strengthen the long-term ties with their customers and increase long-term collaborations.

In China, the Balloon Technology is Widely Known for Innovation - Advanced Technological Solutions.

Attributes Details
China Market Size (2033) USD 413.9 Million
China Market Absolute Dollar Growth (USD Million/Billion) USD 154.6 Million

China controls a sizable portion of the balloon catheter market, accounting for 4.8% of total sales. The balloon catheter market in China is expected to reach a peak of USD 413.9 Million. A few key players claim that the original members of their team are seasoned field professionals from China and the United States.

Their current core teams reputedly have more than a decade of field experience. Key players provide balloon catheters that combine their balloon tubing with 'Earnan Balloon Technology,' which is widely known for innovation and advanced technological solutions. They have pioneered additive manufacturing methods, employing unique techniques and medical-grade materials to produce components with complicated tolerances, geometries, and features.

Newbies are Catching Up with Key Players with Innovative Strategies: Start-up Economy

tart-up companies have introduced advanced technologies to supply premium balloon catheters. This is expected to contribute to the global balloon catheter market growth:

  • MicroPort CardioFlow Medtech Corporation - It creates sophisticated medical gadgets for individuals suffering from heart valve disorders. VitaFlow, a transcatheter aortic valve implantation device created by the business, aids in the treatment of aortic valve stenosis condition in the elderly. It also includes an Alwide Aoguang valve balloon dilatation catheter for surgical aortic valve replacement, as well as an Alpass Ao Shun catheter sheath kit and other items.
  • Gmeditech - It is the creator of a 3D surgical navigation device and balloon catheter fusion method. It created a fusion system that consists of a 3D surgical navigation device and a balloon catheter with a matching degree of 1mm and an internal pressure of 13atm. It is a hybrid surgical navigation system with electromagnetic and optical positioning. The location-tracking balloon catheter monitors the specific position in the body to verify the entrance of the surgical target, such as the frontal sinus, sphenoid sinus, or maxillary sinus, so that balloon dilatation may be conducted at the proper spot.
  • PuChuang - It is a platform for cardiac and vascular intervention technology development. Sonico is an intravascular shock wave balloon catheter system designed to treat arterial vascular calcification.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Companies Revamping the Balloon Catheter Market

The presence of a significant number of prominent players in various regions contributes to the market growth hugely. Ongoing Research and Development (R&D) operations to develop improved technologies, as well as new product innovation provide more potential for the balloon catheter market share.

Novel Developments:

  • In 2020, The Opticross 35 imaging catheter for peripheral imaging was introduced by Boston Scientific Corporation. With a larger IVUS depth and 360-degree clear image quality, this device offers depth and diversity to the company's wide product offering.
  • In 2021, Medtronic PLC has added a new type of catheter to its arsenal: a balloon catheter capable of eluting medications at the site of administration. In the European market for CAD, this device is called the Prevail Drug-Coated Balloon, and it increases the catheter's pushability and its deliverability into complicated anatomies. The medicine on the balloon is absorbed into the target artery tissue, reducing the possibility of in-stent restenosis.
  • In April 2019, The UltraScore 014 focused force percutaneous transluminal angioplasty (PTA) balloon was introduced by Becton, Dickinson, and Company. The UltraScore balloon is designed to dilate stenoses in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries and to treat obstructive lesions in native or synthetic arteriovenous dialysis fistulas.
  • In May 2019, The Advance Enforcer 35 Focal Force PTA balloon catheter was recalled by Cook Medical owing to the balloon bursting below the rated burst pressure.

TOP MARKET PLAYERS OF THE BALLOON CATHETER MARKET:

  • Boston Scientific Inc.
  • Medtronic
  • Terumo Corporation
  • B. Braun Melsungen AG
  • MicroPort Scientific Corporation
  • Jotech GmbH
  • QX Medical LLC
  • Meril Life Pvt. Ltd.
  • Hexacath
  • Abbott Laboratories
  • Tokai Medical Products Inc.
  • Biosensors International Ltd.
  • Cook Medical Inc.
  • Cardionovum GmbH.
  • Cordis Corporation
  • Biotronik
  • Nitinol Device & Components Inc.

Key Segments Profiled in the Balloon Catheter Market Survey

By Product Type:

  • Normal
  • Cutting
  • Scoring
  • Drug Eluting
  • Others

By Raw Material:

  • Polyurethane
  • Nylon
  • Others

By Indication:

  • Coronary Artery Disease
  • Peripheral Vascular Disease

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the Balloon Catheter Market

The market is valued at USD 4.2 billion in 2023. 

What will be the Market CAGR?

The market is estimated to record a CAGR of 4.3% through 2033. 

Who are the key Balloon Catheter Market Players? 

Boston Scientific Inc., Medtronic, and Terumo Corporation are the key market players. 

What Opportunities Await the Market Players? 

The rise in the number of angioplasty patients is to boost the market prospects.

Which is the Projected Key Segment by Raw Material Type? 

The nylon segment is likely to remain preferred through 2033. 

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
  • 5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
    • 5.1. Normal Balloon Catheter
    • 5.2. Cutting Balloon Catheter
    • 5.3. Scoring Balloon Catheter
    • 5.4. Drug Eluting Balloon Catheter
    • 5.5. Stent Graft Balloon Catheter
  • 6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material
    • 6.1. Polyurethane
    • 6.2. Nylon
    • 6.3. Others
  • 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
    • 7.1. Coronary Artery Disease
    • 7.2. Peripheral Vascular Disease
  • 8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
    • 8.1. Hospitals
      • 8.1.1. Private Hospitals
      • 8.1.2. Public Hospitals
    • 8.2. Ambulatory Surgical Centers
    • 8.3. Cardiac Catheterization Laboratories
  • 9. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
    • 9.1. North America
    • 9.2. Latin America
    • 9.3. Eastern Europe
    • 9.4. Western Europe
    • 9.5. Asia Pacific excluding Japan (APEJ)
    • 9.6. Japan
    • 9.7. MEA
  • 10. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 11. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 13. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 14. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 15. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 16. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
  • 17. Key Countries Analysis
  • 18. Market Structure Analysis
  • 19. Competition Analysis
    • 19.1. Boston Scientific Inc.
    • 19.2. Medtronic
    • 19.3. Terumo Corporation
    • 19.4. B. Braun Melsungen AG
    • 19.5. MicroPort Scientific Corporation
    • 19.6. Jotech GmbH
    • 19.7. QX Medical LLC
    • 19.8. Meril Life Pvt. Ltd
    • 19.9. Hexacath
    • 19.10. Abbott Laboratories
    • 19.11. Tokai Medical Products Inc
    • 19.12. Biosensors International Ltd.
    • 19.13. Cook Medical Inc.
    • 19.14. Cardionovum GmbH.
    • 19.15. Cordis Corporation
    • 19.16. Biotronik
    • 19.17. Nitinol Device & Components Inc.
  • 20. Assumptions & Acronyms Used
  • 21. Research Methodology
Recommendations

Healthcare

Stent Graft Balloon Catheter Market

November 2022

REP-GB-1628

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Balloon Catheter Market

Schedule a Call